December 1, 2019

Dear Colleagues and Friends,

Our fourth Alpha Tau Newsletter is full of fantastic updates that I am very excited to share with you.
I am thrilled to inform you that our first clinical trial results have been published! The exceptional results were presented in the I...

November 26, 2019

Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors.

Tel Aviv, Israel, November 26, 2019 – Alpha Tau Medical is pleased to announce the publication of the results of its first clinical trial of Alpha DaRT™, a...

October 7, 2019

October 7 is the birth date of Danish physicist Niels Bohr [1] (1885-1862). Bohr has a special significance for Alpha Tau, for two reasons. The first reason is because he was one of the key contributors to the foundational discoveries in atomic physics at the beginning...

July 2, 2019

Dear Colleagues and Friends, 

I am thrilled to share with you our newest developments achieved in the past months - whether it comes to new collaborations, approvals, research or operational developments, Alpha Tau is rapidly progressing!

In the last several weeks, we ha...

June 18, 2019

We're excited that at this year’s American Brachytherapy Society (ABS) Meeting, Prof. Keisari was awarded the Best Oral Presentation Award at the Breast Plenary Session!

Prof. Keisari presented his results on “Immunomodulation of the Antitumor Response Induced by Alpha...

March 26, 2019

Tel Aviv, Israel, March 26, 2019 – Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that Mr. Raphi Levy will be joining Alpha Tau’s management team as Chief Financial Officer. Mr. Levy will focus primarily on...

February 19, 2019

We are delighted to share with you our first quarterly newsletter of 2019. 

Beyond the great operational progress, our most important advancement this quarter has been the highly promising clinical results from the cancer centers, Rabin Medical Center (RMC) in Israel...

December 20, 2018

Alpha Tau Medical today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9, during the JP Morgan Healthcare week at the Hilton San Francisco Union Square.

Alpha TAU's CEO, Uzi Sofer, will present as follows:

Date: Tuesday, January...

November 7, 2018

Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and Cutaneous and Mucosal malignant Neoplasia (CMN)

TEL AVIV, Israel--(BUSINESS WIRE)--Alpha Tau Medical, developer of a breakthrough alp...

November 5, 2018

The Jewish New Year has now begun, providing us with a great opportunity to kick-off our quarterly Alpha Tau newsletter.

This last year has seen fantastic progress. The significant operational, regulatory and clinical advancement was summarised by additional funding o...

Please reload

Please reload

Sign up
Featured Posts